Company: PETVW
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001641172-25-018617
Chunk: 903

Company: PetVivo Holdings, Inc.
Filing Date: 2025-07-10
Form: 10-K
Item: Item 7
Chunk 903
---
101,823

    Gross Profit

    994,856

    866,883

    OPERATING EXPENSES

    Sales and marketing

    2,644,095

    3,399,666

    Research and development

    1,583,250

    1,395,371

    General and administrative

    4,823,230

    6,693,186

    Total operating expenses

    9,050,575

    11,488,223

    NET OPERATING LOSS

    (8,055,720
    )

    (10,621,340
    )

NOTE
17 – SUBSEQUENT EVENTS

On April 1, 2025, the Company issued 52,500 shares
related to vesting of restricted stock units (“RSUs”).

From April 3, 2025 to July 10, 2025, the Company issued
a total of 68,000 shares to service providers for consulting services with a fair value on the date of grant of $46,420.

On June 6, 2025, the Company issued 70,000 shares
related to a warrant exercise with proceeds of $140,000.

On June 10, 2025, the Company entered
into a short-term convertible promissory note with an accredited investor for $160,000
with an annual interest rate of 10%
and a maturity date of December
31, 2025. The principal amount and all accrued interest of the
convertible note may be converted to shares of common stock (“Shares”) at a conversion price of $0.75 per Share. The Company also issued 75,000 warrants, with a strike price of $0.75, a term of 2 years and a relative fair value of approximately
$20,000, which will be reflected as a discount to the convertible note.

In May and June 2025, the Company received $4,400,000
in connection with the Series B Preferred Stock subscription receivable.

In May and June 2025, three of the
Company Directors collectively entered into three short-term notes in an aggregate amount of $12,000 
with an annual interest rate of 10%
and a maturity date that is the earlier of December
31, 2025, or the closing of our Series B Preferred round.

On
June 10, 2025, the Company issued 225,